InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

KT

Kohler Terry

US·SEC (Form 4)

Verrica Pharmaceuticals Inc.OptiNose, Inc.

0

Total declarations

0

Companies

—

▲ Purchases (0 ops.)

€102,505

▼ Sales (2 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

2

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the detailed record of transactions filed by Kohler Terry. Insider active across 2 companies, notably Verrica Pharmaceuticals Inc.. Aggregated, 8 reports have been logged. Split: 0 buy · 2 sells. Total volume traded: €103k. History available since 24 August 2023. The latest transaction was disclosed on 21 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.

Declarations8 total

●

Chief Financial OfficerExecutives21 May 2025OptiNose, Inc.

30,541 sharesCommon StockSEC:0001104659-25-051349:0

◆

Chief Financial OfficerExecutives21 Feb 2025OptiNose, Inc.

13,875 shares0Common StockSEC:0001494650-25-000011:0

◆

CHIEF FINANCIAL OFFICERExecutives24 Aug 2023Verrica Pharmaceuticals Inc.

125,000 shares0Common StockSEC:0001415889-25-003233:0

◆

Chief Financial OfficerExecutives7 Oct 2024OptiNose, Inc.

150,000 shares0Common StockSEC:0001494650-24-000145:0

▼

CHIEF FINANCIAL OFFICERExecutives26 Aug 2024Verrica Pharmaceuticals Inc.

$58,04142SEC ↗

21,820 shares@ US$2.6650.7% of flowCommon StockSEC:0001415889-24-022424:0

◆

CHIEF FINANCIAL OFFICERExecutives15 Mar 2024Verrica Pharmaceuticals Inc.

40,000 shares0Common StockSEC:0001415889-24-008541:0

▼

Chief Financial OfficerExecutives14 Nov 2023Verrica Pharmaceuticals Inc.

$54,06442SEC ↗

18,452 shares@ US$2.9349.3% of flowCommon StockSEC:0001209191-23-055531:0

◆

Chief Financial OfficerExecutives24 Aug 2023Verrica Pharmaceuticals Inc.

62,500 shares0Common StockSEC:0001209191-23-047524:0

8 of 8 declarations